130 related articles for article (PubMed ID: 3007237)
1. Inhibition of prolactin release and blockade of adenohypophyseal cell cyclic AMP accumulation are two dissociable effects of dopaminergic and non-dopaminergic drugs.
Lafond J; Ducharme JR; Collu R
Mol Cell Endocrinol; 1986 Mar; 44(3):219-25. PubMed ID: 3007237
[TBL] [Abstract][Full Text] [Related]
2. Sodium ions: their role and mechanism of action in the control of prolactin release.
Collu R; Lafond J; Marchisio AM; Eljarmak D; Ducharme JR
Endocrinology; 1984 Apr; 114(4):1302-7. PubMed ID: 6423371
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system.
Memo M; Castelletti L; Missale C; Valerio A; Carruba M; Spano PF
J Neurochem; 1986 Dec; 47(6):1689-95. PubMed ID: 2430058
[TBL] [Abstract][Full Text] [Related]
4. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
Cronin MJ; Thorner MO
J Cyclic Nucleotide Res; 1982; 8(4):267-75. PubMed ID: 6300209
[TBL] [Abstract][Full Text] [Related]
5. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
[TBL] [Abstract][Full Text] [Related]
6. Dopamine and somatostatin inhibit forskolin-stimulated prolactin and growth hormone secretion but not stimulated cyclic AMP levels in sheep anterior pituitary cell cultures.
Ray KP; Gomm JJ; Law GJ; Sigournay C; Wallis M
Mol Cell Endocrinol; 1986 May; 45(2-3):175-82. PubMed ID: 2872092
[TBL] [Abstract][Full Text] [Related]
7. Effects of dopamine on prolactin secretion and cyclic AMP accumulation in the rat anterior pituitary gland.
Ray KP; Wallis M
Biochem J; 1981 Jan; 194(1):119-28. PubMed ID: 6171257
[TBL] [Abstract][Full Text] [Related]
8. Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.
Foord SM; Peters JR; Dieguez C; Shewring G; Hall R; Scanlon MF
Endocrinology; 1986 Apr; 118(4):1319-26. PubMed ID: 3004910
[TBL] [Abstract][Full Text] [Related]
9. Effects of withdrawal of dopamine on translocation of protein kinase C isozymes and prolactin secretion in rat lactotroph-enriched pituitary cells. Modulation of substance P-mediated responses.
Mau SE
J Mol Endocrinol; 1997 Jun; 18(3):181-91. PubMed ID: 9195472
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
Burris TP; Stringer LC; Freeman ME
Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic stimulation of prolactin release.
Denef C; Manet D; Dewals R
Nature; 1980 May; 285(5762):243-6. PubMed ID: 6154895
[TBL] [Abstract][Full Text] [Related]
12. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
[TBL] [Abstract][Full Text] [Related]
13. Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists.
Woolf PD
Am J Physiol; 1981 Jun; 240(6):E700-4. PubMed ID: 7246736
[TBL] [Abstract][Full Text] [Related]
14. Receptor reserve for D2 dopaminergic inhibition of prolactin release in vivo and in vitro.
Meller E; Puza T; Miller JC; Friedhoff AJ; Schweitzer JW
J Pharmacol Exp Ther; 1991 May; 257(2):668-75. PubMed ID: 1674531
[TBL] [Abstract][Full Text] [Related]
15. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization.
Schettini G; Cronin MJ; MacLeod RM
Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710
[TBL] [Abstract][Full Text] [Related]
16. Multiple coupling of neurohormone receptors with cyclic AMP and inositol phosphate production in anterior pituitary cells.
Enjalbert A; Bertrand P; Bockaert J; Drouva S; Kordon C
Biochimie; 1987 Apr; 69(4):271-9. PubMed ID: 2820513
[TBL] [Abstract][Full Text] [Related]
17. Decreased responsiveness of GH3 cells to the dopaminergic inhibition of prolactin.
Faure N; Cronin MJ; Martial JA; Weiner RI
Endocrinology; 1980 Oct; 107(4):1022-6. PubMed ID: 6157521
[TBL] [Abstract][Full Text] [Related]
18. The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells.
Tam SW; Dannies PS
Endocrinology; 1981 Aug; 109(2):403-8. PubMed ID: 6166464
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition.
Chuang TT; Caccavelli L; Kordon C; Enjalbert A
Endocrinology; 1993 Feb; 132(2):832-8. PubMed ID: 7678802
[TBL] [Abstract][Full Text] [Related]
20. Dibutyryl cyclic AMP, adenosine and guanosine blockade of the dopamine, ergocryptine and apomorphine inhibition of prolactin release in vitro.
Hill MK; Macleod RM; Orcutt P
Endocrinology; 1976 Dec; 99(6):1612-7. PubMed ID: 187415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
